Polycystic ovary syndrome, sleep apnea, and daytime sleepiness and fatigue

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Although the study of sleep disorders in the general population as well as in specific groups (i.e., patients with hypothyroidism, peptic, ulcer, hypertension, and others) can be traced to the first sleep disorder clinics in the 1960s [1-3], the interest and published literature on sleep disorders and polycystic ovary syndrome (PCOS) is very recent. It was only in 2001 that the first publication on the association of sleep apnea and sleepiness with PCOS appeared in a scientific journal. The interest on sleep disorders in PCOS was triggered by the first definitive findings that sleep apnea and sleepiness are associated with insulin resistance and central obesity, the latter disorders being the primary pathogenetic mechanisms of PCOS. Thus, this chapter will begin with a summarized discussion of the findings on the association of sleep apnea with insulin resistance and central adipocity, and the role of visceral fat in sleep apnea. The chapter continues with a discussion of the association between PCOS and sleep apnea, insulin resistance, and inflammation, and concludes with the role of psychological distress and pathophysiological factors associated with excessive daytime sleepiness (EDS) in women with PCOS.

Original languageEnglish (US)
Title of host publicationDiagnosis and Management of Polycystic Ovary Syndrome
PublisherSpringer US
Pages143-154
Number of pages12
ISBN (Print)9780387097176
DOIs
StatePublished - Dec 1 2009

Fingerprint

Polycystic Ovary Syndrome
Sleep Apnea Syndromes
Fatigue
Insulin Resistance
Intra-Abdominal Fat
Abdominal Obesity
Hypothyroidism
Peptic Ulcer
Publications
Psychology
Hypertension
Inflammation
Sleep Wake Disorders
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Vgontzas, Alexandros ; Calhoun, Susan. / Polycystic ovary syndrome, sleep apnea, and daytime sleepiness and fatigue. Diagnosis and Management of Polycystic Ovary Syndrome. Springer US, 2009. pp. 143-154
@inbook{b82196c9ab234911ab9bfcfd776fe9cf,
title = "Polycystic ovary syndrome, sleep apnea, and daytime sleepiness and fatigue",
abstract = "Although the study of sleep disorders in the general population as well as in specific groups (i.e., patients with hypothyroidism, peptic, ulcer, hypertension, and others) can be traced to the first sleep disorder clinics in the 1960s [1-3], the interest and published literature on sleep disorders and polycystic ovary syndrome (PCOS) is very recent. It was only in 2001 that the first publication on the association of sleep apnea and sleepiness with PCOS appeared in a scientific journal. The interest on sleep disorders in PCOS was triggered by the first definitive findings that sleep apnea and sleepiness are associated with insulin resistance and central obesity, the latter disorders being the primary pathogenetic mechanisms of PCOS. Thus, this chapter will begin with a summarized discussion of the findings on the association of sleep apnea with insulin resistance and central adipocity, and the role of visceral fat in sleep apnea. The chapter continues with a discussion of the association between PCOS and sleep apnea, insulin resistance, and inflammation, and concludes with the role of psychological distress and pathophysiological factors associated with excessive daytime sleepiness (EDS) in women with PCOS.",
author = "Alexandros Vgontzas and Susan Calhoun",
year = "2009",
month = "12",
day = "1",
doi = "10.1007/978-0-387-09718-3_12",
language = "English (US)",
isbn = "9780387097176",
pages = "143--154",
booktitle = "Diagnosis and Management of Polycystic Ovary Syndrome",
publisher = "Springer US",
address = "United States",

}

Polycystic ovary syndrome, sleep apnea, and daytime sleepiness and fatigue. / Vgontzas, Alexandros; Calhoun, Susan.

Diagnosis and Management of Polycystic Ovary Syndrome. Springer US, 2009. p. 143-154.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Polycystic ovary syndrome, sleep apnea, and daytime sleepiness and fatigue

AU - Vgontzas, Alexandros

AU - Calhoun, Susan

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Although the study of sleep disorders in the general population as well as in specific groups (i.e., patients with hypothyroidism, peptic, ulcer, hypertension, and others) can be traced to the first sleep disorder clinics in the 1960s [1-3], the interest and published literature on sleep disorders and polycystic ovary syndrome (PCOS) is very recent. It was only in 2001 that the first publication on the association of sleep apnea and sleepiness with PCOS appeared in a scientific journal. The interest on sleep disorders in PCOS was triggered by the first definitive findings that sleep apnea and sleepiness are associated with insulin resistance and central obesity, the latter disorders being the primary pathogenetic mechanisms of PCOS. Thus, this chapter will begin with a summarized discussion of the findings on the association of sleep apnea with insulin resistance and central adipocity, and the role of visceral fat in sleep apnea. The chapter continues with a discussion of the association between PCOS and sleep apnea, insulin resistance, and inflammation, and concludes with the role of psychological distress and pathophysiological factors associated with excessive daytime sleepiness (EDS) in women with PCOS.

AB - Although the study of sleep disorders in the general population as well as in specific groups (i.e., patients with hypothyroidism, peptic, ulcer, hypertension, and others) can be traced to the first sleep disorder clinics in the 1960s [1-3], the interest and published literature on sleep disorders and polycystic ovary syndrome (PCOS) is very recent. It was only in 2001 that the first publication on the association of sleep apnea and sleepiness with PCOS appeared in a scientific journal. The interest on sleep disorders in PCOS was triggered by the first definitive findings that sleep apnea and sleepiness are associated with insulin resistance and central obesity, the latter disorders being the primary pathogenetic mechanisms of PCOS. Thus, this chapter will begin with a summarized discussion of the findings on the association of sleep apnea with insulin resistance and central adipocity, and the role of visceral fat in sleep apnea. The chapter continues with a discussion of the association between PCOS and sleep apnea, insulin resistance, and inflammation, and concludes with the role of psychological distress and pathophysiological factors associated with excessive daytime sleepiness (EDS) in women with PCOS.

UR - http://www.scopus.com/inward/record.url?scp=84891441190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891441190&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-09718-3_12

DO - 10.1007/978-0-387-09718-3_12

M3 - Chapter

AN - SCOPUS:84891441190

SN - 9780387097176

SP - 143

EP - 154

BT - Diagnosis and Management of Polycystic Ovary Syndrome

PB - Springer US

ER -